Allergan USA, Inc. v. Imprimis Pharmaceuticals, Inc.
| ALLERGAN USA, INC. |
| IMPRIMIS PHARMACEUTICALS, INC. |
| 19-55999 |
| August 27, 2019 |
| U.S. Court of Appeals, Ninth Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 3, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 Filed order (Deputy Clerk: RGA) The conference previously scheduled for October 7, 2019, is canceled. Pursuant to the stipulation of the parties (Docket Entry No. [ # 11451855-4 ]), these appeals are voluntarily dismissed. Fed. R. App. P. 42(b). A copy of this order shall serve as and for the mandate of this court. [11453267] [19-55756, 19-55999] (OC) [Entered: 10/03/2019 02:24 PM] |
| Filing 6 Filed (ECF) Appellee Allergan USA, Inc. Joint Motion to dismiss case voluntarily pursuant to FRAP 42(b). Date of service: 10/02/2019. [11451796] --[COURT ENTERED FILING to correct entry [5] .] (TYL) [Entered: 10/02/2019 02:31 PM] |
| Filing 5 COURT DELETED INCORRECT ENTRY. Notice about deletion sent to case participants registered for electronic filing. Correct Entry: [ # 6 ]. Original Text: Filed (ECF) Appellee Allergan USA, Inc. Correspondence: JOINT STIPULATION BY ALLERGAN USA, INC. AND IMPRIMIS PHARMACEUTICALS, INC. TO VOLUNTARILY DISMISS APPEALS. Date of service: 10/02/2019 [11451762] [19-55999] (Akrotirianakis, Joseph) [Entered: 10/02/2019 02:21 PM] |
| Filing 4 MEDIATION CONFERENCE SCHEDULED - Assessment Conference, 10/07/2019, 11:00 a.m. PACIFIC Time. The briefing schedule previously set by the court remains in effect. See order for instructions and details. [11431646] [19-55756, 19-55999] (CL) [Entered: 09/13/2019 04:11 PM] |
| Filing 3 The Mediation Questionnaire for this case was filed on 09/03/2019. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[11419714][19-55999] (AD) [Entered: 09/04/2019 06:44 AM] |
| Filing 2 Filed (ECF) Appellant Imprimis Pharmaceuticals, Inc. Mediation Questionnaire. Date of service: 09/03/2019. [11419665] [19-55999] (Wesley, Keith) [Entered: 09/03/2019 08:00 PM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Mediation Questionnaire due on 09/03/2019. Transcript ordered by 09/26/2019. Transcript due 10/25/2019. Appellant Imprimis Pharmaceuticals, Inc. opening brief due 12/05/2019. Appellee Allergan USA, Inc. answering brief due 01/06/2020. Appellant's optional reply brief is due 21 days after service of the answering brief. [11412028] (RT) [Entered: 08/27/2019 01:16 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
